Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Defects, Congenital | 6 | 2024 | 1817 | 1.340 |
Why?
|
Resilience, Psychological | 3 | 2024 | 73 | 1.280 |
Why?
|
Adaptation, Psychological | 2 | 2024 | 451 | 0.920 |
Why?
|
Caregivers | 2 | 2024 | 577 | 0.790 |
Why?
|
Vasodilator Agents | 1 | 2022 | 200 | 0.730 |
Why?
|
Mental Health | 1 | 2023 | 346 | 0.700 |
Why?
|
Vascular Malformations | 1 | 2021 | 87 | 0.690 |
Why?
|
Pulmonary Veins | 1 | 2021 | 161 | 0.660 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2022 | 252 | 0.630 |
Why?
|
Cardiac Catheterization | 1 | 2022 | 632 | 0.610 |
Why?
|
Physicians | 1 | 2022 | 579 | 0.490 |
Why?
|
Neural Stem Cells | 3 | 2023 | 124 | 0.470 |
Why?
|
Patient Education as Topic | 3 | 2024 | 441 | 0.420 |
Why?
|
Heart Failure | 1 | 2024 | 2155 | 0.380 |
Why?
|
Spinal Cord | 4 | 2023 | 303 | 0.370 |
Why?
|
Fontan Procedure | 2 | 2024 | 187 | 0.340 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2023 | 195 | 0.310 |
Why?
|
Quality of Life | 3 | 2024 | 1943 | 0.260 |
Why?
|
Cellular Reprogramming | 2 | 2023 | 116 | 0.220 |
Why?
|
Interviews as Topic | 1 | 2024 | 377 | 0.210 |
Why?
|
Injections, Spinal | 1 | 2023 | 120 | 0.210 |
Why?
|
Nociceptors | 1 | 2022 | 15 | 0.200 |
Why?
|
Adolescent | 6 | 2024 | 19300 | 0.190 |
Why?
|
Young Adult | 3 | 2024 | 8974 | 0.190 |
Why?
|
Neuralgia | 1 | 2022 | 45 | 0.190 |
Why?
|
Gene Transfer Techniques | 2 | 2022 | 357 | 0.190 |
Why?
|
Qualitative Research | 1 | 2024 | 548 | 0.190 |
Why?
|
Cyanosis | 1 | 2021 | 42 | 0.180 |
Why?
|
Stem Cell Transplantation | 1 | 2023 | 236 | 0.180 |
Why?
|
Pia Mater | 1 | 2019 | 10 | 0.170 |
Why?
|
Heart Diseases | 1 | 2024 | 485 | 0.160 |
Why?
|
Humans | 14 | 2024 | 124307 | 0.160 |
Why?
|
Multipotent Stem Cells | 1 | 2019 | 29 | 0.160 |
Why?
|
Motor Neurons | 1 | 2019 | 141 | 0.160 |
Why?
|
Gene Silencing | 1 | 2019 | 238 | 0.160 |
Why?
|
Biopsy | 1 | 2022 | 1237 | 0.160 |
Why?
|
Nerve Degeneration | 1 | 2019 | 126 | 0.160 |
Why?
|
Dependovirus | 1 | 2019 | 130 | 0.150 |
Why?
|
Exercise | 1 | 2024 | 815 | 0.150 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 146 | 0.150 |
Why?
|
Heart Transplantation | 1 | 2024 | 858 | 0.150 |
Why?
|
Swine | 4 | 2023 | 1173 | 0.140 |
Why?
|
Flow Cytometry | 1 | 2019 | 802 | 0.130 |
Why?
|
Echocardiography | 1 | 2021 | 1052 | 0.130 |
Why?
|
Liver | 1 | 2022 | 1761 | 0.120 |
Why?
|
Adult | 6 | 2024 | 29385 | 0.110 |
Why?
|
Prospective Studies | 1 | 2022 | 6071 | 0.100 |
Why?
|
Male | 7 | 2024 | 60964 | 0.090 |
Why?
|
Child | 4 | 2024 | 24435 | 0.080 |
Why?
|
Female | 7 | 2024 | 66236 | 0.080 |
Why?
|
Infant, Newborn | 1 | 2021 | 8181 | 0.080 |
Why?
|
Infant | 1 | 2021 | 12473 | 0.060 |
Why?
|
Surveys and Questionnaires | 2 | 2024 | 3722 | 0.060 |
Why?
|
Rats | 2 | 2023 | 3686 | 0.060 |
Why?
|
Microdialysis | 1 | 2003 | 56 | 0.050 |
Why?
|
Extracellular Space | 1 | 2003 | 88 | 0.050 |
Why?
|
Sendai virus | 1 | 2023 | 4 | 0.050 |
Why?
|
Program Development | 1 | 2024 | 186 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2023 | 1930 | 0.050 |
Why?
|
Lactic Acid | 1 | 2003 | 147 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2023 | 40 | 0.050 |
Why?
|
Spinal Cord Dorsal Horn | 1 | 2022 | 2 | 0.050 |
Why?
|
Posterior Horn Cells | 1 | 2022 | 5 | 0.050 |
Why?
|
Specimen Handling | 1 | 2023 | 140 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2024 | 761 | 0.050 |
Why?
|
Brain | 2 | 2023 | 3003 | 0.050 |
Why?
|
Health Promotion | 1 | 2024 | 392 | 0.040 |
Why?
|
Graft Survival | 1 | 2023 | 531 | 0.040 |
Why?
|
Pilot Projects | 1 | 2024 | 1401 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 2535 | 0.040 |
Why?
|
Superoxide Dismutase-1 | 1 | 2019 | 24 | 0.040 |
Why?
|
Evoked Potentials, Motor | 1 | 2019 | 33 | 0.040 |
Why?
|
Primates | 1 | 2019 | 80 | 0.040 |
Why?
|
Muscle Development | 1 | 2019 | 71 | 0.040 |
Why?
|
Animals | 4 | 2023 | 34153 | 0.040 |
Why?
|
Atrophy | 1 | 2019 | 236 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2023 | 940 | 0.040 |
Why?
|
Longevity | 1 | 2020 | 140 | 0.040 |
Why?
|
Protein Folding | 1 | 2019 | 218 | 0.040 |
Why?
|
Telemedicine | 1 | 2024 | 439 | 0.040 |
Why?
|
Glucose | 1 | 2003 | 885 | 0.040 |
Why?
|
Transplantation, Isogeneic | 1 | 2018 | 15 | 0.040 |
Why?
|
Neostriatum | 1 | 2018 | 11 | 0.040 |
Why?
|
Interneurons | 1 | 2019 | 142 | 0.040 |
Why?
|
Swine, Miniature | 1 | 2018 | 46 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2018 | 69 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 670 | 0.040 |
Why?
|
Immune Tolerance | 1 | 2018 | 145 | 0.040 |
Why?
|
Brain Injuries | 1 | 2003 | 764 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 661 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 3425 | 0.030 |
Why?
|
Skin | 1 | 2018 | 511 | 0.030 |
Why?
|
Spinal Cord Injuries | 1 | 2018 | 311 | 0.030 |
Why?
|
Survival Analysis | 1 | 2018 | 1482 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2019 | 2410 | 0.030 |
Why?
|
Registries | 1 | 2020 | 1410 | 0.030 |
Why?
|
Chronic Disease | 1 | 2018 | 1185 | 0.030 |
Why?
|
Cell Line | 1 | 2019 | 2773 | 0.030 |
Why?
|
Fibroblasts | 1 | 2018 | 890 | 0.030 |
Why?
|
Disease Progression | 1 | 2019 | 2039 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2019 | 2824 | 0.030 |
Why?
|
Inflammation | 1 | 2019 | 1414 | 0.030 |
Why?
|
Aging | 1 | 2018 | 1185 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 4426 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2023 | 12292 | 0.020 |
Why?
|
Neurons | 1 | 2018 | 1966 | 0.020 |
Why?
|
Middle Aged | 2 | 2024 | 26451 | 0.020 |
Why?
|
Mice | 1 | 2022 | 17732 | 0.020 |
Why?
|
United States | 1 | 2020 | 10766 | 0.010 |
Why?
|
Glasgow Coma Scale | 1 | 2003 | 204 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 253 | 0.010 |
Why?
|